- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07531641
From Screening to Safety: Implementing the AL-STEADI Initiative in Assisted Living Communities (AL-STEADI)
April 9, 2026 updated by: Brown University
The goal of this trial is to test the real-world efficacy of AL-STEADI, a fall prevention program, in seven assisted living centers.
We will randomly assign 700 residents from seven assisted living centers who screen at-risk of falling to either existing fall monitoring protocols or the enhanced AL-STEADI fall prevention program.
We will evaluate the effect of AL-STEADI on the rate of falls over 12 months.
We will also closely monitor implementation fidelity in these seven assisted living centers.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
700
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ellen McCreedy, PhD, MPH
- Phone Number: (401) 863-7345
- Email: ellen_mccreedy@brown.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria: This is a pragmatic trial. All residents living in one of the seven participating assisted living communities will be potentially eligible. Residents who screen positive for fall risk will be enrolled.
-
Exclusion Criteria: Not living in one of seven partnering assisted living centers. Not screening at-risk for falls.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AL-STEADI
|
STEADI is an evidence-based falls prevention program developed by the CDC and tested in several community-based settings.
STEADI involves universal fall screening, followed by personalized assessments and tailored interventions.
Common, potentially modifiable causes of falls evaluated in STEADI include medication interactions or side effects, environmental hazards (e.g., floor rugs, thresholds), untreated visual impairment, low vitamin D, ill-fitting footwear, or low blood pressure.
AL-STEADI is a modified version of STEADI for assisted living.
|
|
Active Comparator: Existing fall monitoring protocols
|
Typical fall prevention practices, including increased monitoring by assisted living staff
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fall rate
Time Frame: 12 person-months
|
Number of staff documented falls per 12 non-censored person-months, among individuals who screen at-risk for falls
|
12 person-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2027
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
September 1, 2029
Study Registration Dates
First Submitted
April 9, 2026
First Submitted That Met QC Criteria
April 9, 2026
First Posted (Actual)
April 15, 2026
Study Record Updates
Last Update Posted (Actual)
April 15, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- U01CE003720 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Resident-level, electronic medical record data will be protected by Data Use Agreements and cannot be shared publicly.
Summary tables may be made available; small cell restrictions and other measures to prevent re-identification would apply
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fall
-
University of AmsterdamCompletedDeprescribing | Fall | Fall Injury | Fall Patients | Accidental FallNetherlands
-
Betul Esra CevikCompletedAccidental Fall | Fall Prevention | Fall Risk FactorsTurkey (Türkiye)
-
University of Illinois at Urbana-ChampaignUnknownFall Injury | Fall Prevention | Fall Safety
-
Massachusetts General HospitalCricoCompletedFall Injury | Fall PatientsUnited States
-
University of ArizonaVirginia Polytechnic Institute and State UniversityNot yet recruiting
-
Neuroscience Research AustraliaThe University of New South WalesCompleted
-
Aalborg University HospitalCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of AmsterdamNot yet recruitingFall | Aged | Fall Injury | Fall Patients | Polypharmacy | Accidental Fall | Aged, 80 and Over | DeprescriptionsNetherlands
-
Dalarna UniversitySormland County Council, SwedenRecruiting
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany
Clinical Trials on AL-STEADI
-
King Abdullah University HospitalJordan University of Science and TechnologyCompleted
-
Alcon ResearchWithdrawn
-
Alios Biopharma Inc.Completed
-
Hospital General Universitario ElcheUnknown
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
University of California, San FranciscoCompletedProgressive Supranuclear Palsy | Corticobasal Degeneration Syndrome | Progressive Nonfluent Aphasia | Predicted Tauopathies, Including | Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17United States
-
Riphah International UniversityCompletedStuttering, AdultPakistan
-
Common SenseCompletedAmniotic ProblemsUnited States